Navigation Links
Coloplast Wins Patent Infringement Verdict Against Generic Medical Devices, Inc.
Date:5/8/2012

MINNEAPOLIS, May 8, 2012 /PRNewswire/ -- Coloplast North America today announced that a federal court jury in Tacoma, Wash., ruled that Generic Medical Devices, Inc. (GMD) was infringing on a Coloplast Urology Care patent for the transobturator (TOT) method for treating stress urinary incontinence in women. Using this approach, surgeons implant Coloplast's Aris® sling to help women regain control of their bladder.

The jury found that GMD infringed six separate claims of U.S. Patent Number 7,621,864, by marketing and selling its surgical tools and sling products for the purpose of using the TOT surgical method patented by Coloplast. The court soon will schedule a briefing on Coloplast's motion for a permanent injunction.

"By pursuing and winning this patent case, Coloplast is able to protect the research and development investments we make," said Steffen Hovard, senior vice president of Coloplast Urology Care. "Our mission is to improve patient quality of life. Protecting our patents allows us to realize that mission and push the industry forward through innovation. This is how we bring the best technologies, best devices and best methods to our surgeon partners and patients."

Coloplast was represented in the patent case by Faegre Baker Daniels LLP.

About Aris®

Aris® is a sling used to treat stress urinary incontinence in women. The Aris sling is implanted using the newest effective treatment approach, transobturator, which places the sling in a hammock position cradling the urethra. When in place, the sling supports and keeps the urethra in the correct position without the use of screws, anchors or sutures.

About Coloplast

Danish medical device company Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare.

Coloplast's business includes ostomy care, urology, continence care, and wound and skin care. Coloplast operates globally and employs more than 7,500 people worldwide. In 2009, Coloplast opened the new North American headquarters in Minneapolis, Minnesota. The campus is LEED-certified (Leadership in Energy and Environmental Design) and is home to one of the company's three global research-and-development Innovation Centers. Others are located in Denmark and France.

To learn more about Coloplast, visit www.us.coloplast.com and www.straighttalk.net.


'/>"/>
SOURCE Coloplast
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Coloplast Selected By LifeScience Alley to Host Minnesota Medical Device Panel
2. Bio-AMD, Inc.; Patent Application for Cartridge Test Cap
3. Broad Patent Protection Granted for iBio Immunomodulator
4. DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology
5. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
6. U.S. Patent Office Issues Sixth Patent Covering Zero-Footprint Medical Image Viewers to Heart Imaging Technologies, LLC
7. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
8. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
9. Essential Medical Dismisses Patent Case against Masimo and Cercacor
10. Watson Confirms Favorable District Court Ruling in Generic Sanctura XR® Patent Suit
11. Inovio Receives U.S. Patent for SynCon® H1N1 Influenza Universal Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... Research and Markets has announced the ... 2016 - Forecast to 2022" report to their offering. ... up to date financial data derived from varied research sources ... with potential impact on the market during the next five ... comprises of sub markets, regional and country level analysis. The ...
(Date:6/23/2016)... Ill. and INDIANAPOLIS , ... students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship is ... 2016 scholarship winners, announced today online at www.diabetesscholars.org ... let type 1 diabetes stand in the way of ... has supported the Foundation,s scholarship program since 2012, and ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
Breaking Medicine News(10 mins):